D'INCALCI, MAURIZIO
 Distribuzione geografica
Continente #
EU - Europa 1.501
NA - Nord America 1.463
AS - Asia 1.329
SA - Sud America 263
OC - Oceania 46
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.626
Nazione #
US - Stati Uniti d'America 1.246
CN - Cina 556
IT - Italia 491
GB - Regno Unito 203
DE - Germania 183
JP - Giappone 148
CA - Canada 116
TR - Turchia 113
ES - Italia 99
PL - Polonia 85
TW - Taiwan 85
KR - Corea 80
MX - Messico 78
FR - Francia 68
PE - Perù 59
BR - Brasile 57
CH - Svizzera 47
CO - Colombia 46
BE - Belgio 42
AU - Australia 37
SE - Svezia 36
IL - Israele 35
IN - India 35
CL - Cile 34
RO - Romania 34
TH - Thailandia 34
NL - Olanda 33
SG - Singapore 33
IE - Irlanda 32
HK - Hong Kong 29
EC - Ecuador 28
SA - Arabia Saudita 24
VN - Vietnam 23
ID - Indonesia 22
UA - Ucraina 20
AR - Argentina 18
AT - Austria 18
IR - Iran 16
DK - Danimarca 15
CZ - Repubblica Ceca 14
PT - Portogallo 14
HU - Ungheria 13
LB - Libano 13
GR - Grecia 12
JO - Giordania 12
PH - Filippine 11
GY - Guiana 10
MY - Malesia 10
PS - Palestinian Territory 10
SK - Slovacchia (Repubblica Slovacca) 10
AE - Emirati Arabi Uniti 9
MO - Macao, regione amministrativa speciale della Cina 9
NZ - Nuova Zelanda 9
PR - Porto Rico 9
LV - Lettonia 7
RU - Federazione Russa 7
NI - Nicaragua 6
KZ - Kazakistan 5
NG - Nigeria 5
QA - Qatar 5
BO - Bolivia 4
EG - Egitto 4
PK - Pakistan 4
SN - Senegal 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
SI - Slovenia 3
TN - Tunisia 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
CR - Costa Rica 2
ET - Etiopia 2
FI - Finlandia 2
GE - Georgia 2
HN - Honduras 2
IQ - Iraq 2
LT - Lituania 2
MN - Mongolia 2
RS - Serbia 2
SV - El Salvador 2
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HR - Croazia 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PA - Panama 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
ZA - Sudafrica 1
Totale 4.626
Città #
Guangzhou 67
Shanghai 66
Redwood City 64
Beijing 52
Lima 49
Milan 49
Ann Arbor 48
Turin 42
Fairfield 41
Chandler 40
Dundee 35
Torino 35
Cambridge 32
Houston 31
Istanbul 31
Tokyo 30
Dublin 29
Wilmington 29
Taipei 28
Ashburn 27
Ithaca 27
Rome 25
Seattle 25
Bogotá 22
Stuttgart 22
Woodbridge 22
Wuhan 22
Nanjing 21
Toronto 21
Iowa City 20
Seoul 20
Zurich 19
Chengdu 17
Marcellus 17
Santiago 17
Bangkok 16
Brooklyn 16
Brussels 16
Bucharest 16
Florence 16
Barcelona 15
London 15
Medellín 15
Singapore 15
New York 14
Paris 14
Bursa 13
Hangzhou 13
Nyköping 13
Chicago 12
Concepción 12
Shenzhen 12
Tianjin 12
Denver 11
Jeddah 11
Medford 11
Quito 11
Sydney 11
Warsaw 11
Changchun 10
Chongqing 10
Guayaquil 10
Madrid 10
Vienna 10
Washington 10
Xian 10
Bologna 9
Gaza 9
Gustavo Adolfo Madero 9
Jinan 9
Naples 9
Ottawa 9
Philadelphia 9
Shenyang 9
Xi'an 9
Amman 8
Ankara 8
Berlin 8
Boston 8
Dong Ket 8
Duncan 8
Frankfurt am Main 8
Leuven 8
Luni 8
New Taipei 8
Polska 8
Saint Augustine 8
Sheffield 8
Tübingen 8
Wroclaw 8
Basel 7
Belton 7
Carrara 7
Central 7
Columbus 7
Gainesville 7
Genoa 7
Leeds 7
Liverpool 7
Los Angeles 7
Totale 1.804
Nome #
High-dose Vitamin C enhances cancer immunotherapy 4.142
Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype 183
Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells 79
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin 76
New activities for the anti-tumor agent trabectedin: Taking two birds with one stone 68
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 63
Trabectedin: A drug from the sea that strikes tumor-associated macrophages 53
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group 25
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line 2
Totale 4.691
Categoria #
all - tutte 7.135
article - articoli 0
book - libri 0
conference - conferenze 279
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.414


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 0 0 0 2 0 1 4 3 3 2 2 27
2020/2021686 2 37 77 45 38 79 64 68 101 69 34 72
2021/20221.173 67 79 114 118 127 99 100 100 123 89 86 71
2022/20231.332 62 57 131 93 75 127 136 110 155 114 174 98
2023/20241.387 145 118 137 149 149 101 79 121 40 146 99 103
2024/202520 20 0 0 0 0 0 0 0 0 0 0 0
Totale 4.691